About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Incretins
- Company
- University of Campania Luigi Vanvitelli
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 31 recruiting
Efficacy results: Not yet reported
31 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026
Find a Clinical Trial Near Me
See recruiting studies for Incretins and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT01851694
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
Not yet reported University of Pennsylvania 45 participants Est. completion 2026-12 1 siteOther conditions: Cystic Fibrosis, Pancreatic InsufficiencyView official trial listing → -
Recruiting NCT NCT01852448
Genetics of Insulin and Incretins in Cystic Fibrosis
Children's Hospital of Philadelphia 550 participants Est. completion 2026-07 2 sitesOther conditions: Cystic FibrosisView official trial listing → -
Recruiting NCT NCT04615546
Role of Nutrient Transit in Hyperinsulinemic Hypoglycemia
Not yet reported Stanford University 60 participants Est. completion 2026-06 1 siteOther conditions: Post-Bariatric HypoglycemiaView official trial listing → -
Recruiting NCT NCT06374875
Fibrosis Lessens After Metabolic Surgery
Not yet reported The Cleveland Clinic 120 participants Est. completion 2029-12-31 22 sitesMASLDMASH Other conditions: Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, ObesityView official trial listing → -
Recruiting NCT NCT06395246
Circulating Microvesicles Regulating Metabolic Homeostasis in Obesity After Caloric Restriction Programs
Not yet reported Institut Investigacio Sanitaria Pere Virgili 60 participants Est. completion 2025-12-20 1 siteOther conditions: ObesityView official trial listing → -
Recruiting NCT NCT06431308
Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events
Not yet reported Ariel University 120 participants Est. completion 2026-03-30 3 sitesOther conditions: Obesity; DrugView official trial listing → -
Recruiting NCT NCT06487832
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
Not yet reported University Hospital Tuebingen 60 participants Est. completion 2027-12-31 1 siteOther conditions: Normal Weight, Overweight and Obesity, Insulin Sensitivity, Insulin ResistanceView official trial listing → -
Recruiting NCT NCT06630585
GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
Not yet reported University of Bern 42 participants Est. completion 2026-06 3 sitesOther conditions: Type 1 Diabetes (T1D)View official trial listing → -
Recruiting NCT NCT06734312
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
Not yet reported Dr. Christopher McGowan 20 participants Est. completion 2026-06 2 sites Added to GLP-1Other conditions: Obesity and Obesity-related Medical Conditions, Obesity and Overweight, Obesity Prevention, Obesity Recidivism, GLP-1, Ablation TechniquesView official trial listing → -
Recruiting NCT NCT06790225
Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)
Not yet reported Esbjerg Hospital - University Hospital of Southern Denmark 12 participants Est. completion 2027-11-30 1 siteType 2 diabetes Other conditions: Bone Disease, Metabolic, Obesity and Obesity-related Medical ConditionsView official trial listing → -
Recruiting NCT NCT06820281
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
Not yet reported Victor Chang Cardiac Research Institute 44 participants Est. completion 2027-12-31 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Recruiting NCT NCT06856291
Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance
ETH Zurich 40 participants Est. completion 2026-08-31 1 siteOther conditions: Obesity and Obesity-related Medical Conditions, Obesity and Overweight, Insulin Sensitivity/Resistance, SemaglutideView official trial listing → -
Recruiting NCT NCT07058155
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
Not yet reported The Cleveland Clinic 70 participants Est. completion 2034-02-01 1 siteOther conditions: Liver Cirrhoses, Portal Hypertension Related to Cirrhosis, Severe Obesity, TIPSView official trial listing → -
Recruiting NCT NCT07095517
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
Not yet reported Massachusetts General Hospital 20 participants Est. completion 2028-12-31 1 siteOther conditions: Colorectal Cancer Prevention, Colorectal AdenomaView official trial listing → -
Recruiting NCT NCT07165028
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Not yet reported Eli Lilly and Company 4500 participants Est. completion 2032-08 563 sitesMASLDView official trial listing → -
Recruiting NCT NCT07169851
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Not yet reported Eli Lilly and Company 204 participants Est. completion 2027-02 68 sitesOther conditions: Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions, NeoplasmsView official trial listing → -
Recruiting NCT NCT07219173
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Not yet reported Eli Lilly and Company 531 participants Est. completion 2028-06 121 sitesOther conditions: AsthmaView official trial listing → -
Recruiting NCT NCT07226947
Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment
Not yet reported Massachusetts General Hospital 100 participants Est. completion 2027-06 1 siteOther conditions: Obesity, Body CompositionView official trial listing → -
Recruiting NCT NCT07228741
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
Not yet reported St. Jude Children's Research Hospital 20 participants Est. completion 2028-11 1 siteOther conditions: Acute Lymphoblastic Leukemia, ObesityView official trial listing → -
Recruiting NCT NCT07271043
Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics
Not yet reported Joslin Diabetes Center 60 participants Est. completion 2026-12-01 1 siteType 2 diabetesView official trial listing → -
Recruiting NCT NCT07284511
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
Not yet reported, Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 105 participants Est. completion 2029-01 4 sitesOther conditions: Type 1 Diabetes, Type 1 Diabetes Mellitus, T1D, T1DM, T1DM - Type 1 Diabetes MellitusView official trial listing → -
Recruiting NCT NCT07325500
Incretin Microdosing for Cardiometabolic Health in People With HIV
Not yet reported The University of Texas Health Science Center, Houston 30 participants Est. completion 2029-06-30 1 siteOther conditions: Weight GainView official trial listing → -
Recruiting NCT NCT07392190
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Not yet reported Eli Lilly and Company 900 participants Est. completion 2028-07 187 sitesOther conditions: Overweight, ObesityView official trial listing → -
Recruiting NCT NCT07409831
Incretin-based Therapies, Nutrition, and Physical Activity
Not yet reported Laval University 120 participants Est. completion 2028-03 2 sitesOther conditions: Obesity & Overweight, Cardiometabolic ConditionsView official trial listing → -
Recruiting NCT NCT07411560
A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese
Not yet reported Novo Nordisk A/S 100 participants Est. completion 2027-01-26 1 siteOther conditions: Overweight, ObeseView official trial listing → -
Recruiting NCT NCT07481747
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)
Not yet reported Hudson Biotech 2539 participants Est. completion 2028-03-17 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Recruiting NCT NCT07554638
Incretin Therapies in Obesity-related HFpEF
Not yet reported Columbia University 50 participants Est. completion 2030-04 1 siteHeart failure Other conditions: ObesityView official trial listing → -
Recruiting NCT NCT07588438
Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
Not yet reported Las Rías Medical Center 160 participants Est. completion 2027-08-10 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Recruiting NCT NCT07589322
Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs
Not yet reported Tri-Service General Hospital (TSGH) 120 participants Est. completion 2029-09-30 1 siteMetabolic syndromeView official trial listing → -
Recruiting NCT NCT07619989
Transcutaneous Auricular Vagus Nerve Stimulation for Poor Weight-Loss Response to Incretin Receptor Agonists
Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 24 participants Est. completion 2027-09-01 1 siteOther conditions: Obesity & OverweightView official trial listing → -
Recruiting NCT NCT07776509
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Not yet reported AstraZeneca 500 participants Est. completion 2028-08-09 96 sitesType 2 diabetes Other conditions: Obesity or Overweight, Weight-Related ComorbidityView official trial listing → -
Completed NCT NCT00321321
The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes
Not yet reported University Hospital, Gentofte, Copenhagen 12 participants Est. completion 2007-04 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00361946
The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).
Baylor College of Medicine 45 participants Est. completion 2010-07 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00364377
Incretins in Impaired Fasting Glucose
Not yet reported Mayo Clinic 22 participants Est. completion 2008-12 1 sitePrediabetesView official trial listing → -
Completed NCT NCT00396071
Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin
Not yet reported Novartis Pharmaceuticals 22 participants 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00411411
Long Term Effects of DPP-IV Inhibitor Treatment in Patients With Type 2 Diabetes
Not yet reported University Hospital, Gentofte, Copenhagen 49 participants Est. completion 2009-03 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00451113
Sitagliptin in the Elderly
Not yet reported University of British Columbia 12 participants Est. completion 2012-11 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00469833
Insulin Secretion in Diabetes Before and After Glycemic Control
Not yet reported US Department of Veterans Affairs 17 participants Est. completion 2012-09 1 siteOther conditions: Diabetes, HyperglycemiaView official trial listing → -
Completed NCT NCT00501657
Effects of Sitagliptin on Gastric Emptying in Healthy Subjects
Not yet reported Royal Adelaide Hospital 15 participants Est. completion 2011-12 1 siteOther conditions: Gastroparesis, Diabetes MellitusView official trial listing → -
Completed NCT NCT00529048
Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes
Herlev Hospital 16 participants Est. completion 2009-09 1 siteOther conditions: Incretin EffectView official trial listing → -
Completed NCT NCT00551590
Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes Mellitus
Not yet reported Ludwig-Maximilians - University of Munich 24 participants Est. completion 2011-09 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00571220
Mechanisms of Diabetes Control After Weight Loss Surgery
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 20 participants Est. completion 2010-12 1 siteOther conditions: Gastric Bypass Surgery, ObesityView official trial listing → -
Completed NCT NCT00575588
52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period
Not yet reported AstraZeneca 891 participants Est. completion 2010-08 94 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00603031
Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus
Not yet reported Hvidovre University Hospital 9 participants Est. completion 2008-06 1 siteOther conditions: Type-1 Diabetes MellitusView official trial listing → -
Terminated NCT NCT00609154
Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
Not yet reported, Not yet reported Albert Einstein College of Medicine 20 participants Est. completion 2014-05-13 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00612950
Beta-Cell Function After Near-Normalisation of Blood Glucose
Not yet reported Hvidovre University Hospital 8 participants Est. completion 2007-05 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00614939
Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment
Not yet reported AstraZeneca 572 participants Est. completion 2010-03 74 sitesType 2 diabetesView official trial listing → -
Terminated NCT NCT00625040
Incretin Physiology and Beta-cell Function Before and After Weight-loss
Glostrup University Hospital, Copenhagen 10 participants Est. completion 2011-01 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT00627744
Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction
Not yet reported Karolinska Institutet 85 participants Est. completion 2010-11 2 sitesCardiovascular diseasePrediabetes Other conditions: Unstable Angina Pectoris, Diabetes MellitusView official trial listing → -
Completed NCT NCT00638573
The Incretin Effect in Patients With Chronic Pancreatitis
University Hospital, Gentofte, Copenhagen 32 participants Est. completion 2006-07 1 siteType 2 diabetes Other conditions: Chronic PancreatitisView official trial listing → -
Completed NCT NCT00638716
A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy
Not yet reported ConjuChem 122 participants Est. completion 2008-11 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT00647023
Incretin Secretion in Women With Polycystic Ovary Syndrome (PCOS)
Not yet reported Hvidovre University Hospital 66 participants Est. completion 2006-05Other conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT00656864
Pioglitazone Incretin Study
Not yet reported University of Vermont 24 participants Est. completion 2010-11 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00661362
Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes
Not yet reported AstraZeneca 570 participants Est. completion 2009-09 30 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00674466
A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy
Not yet reported ConjuChem 90 participants Est. completion 2008-11 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00683735
Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis
Not yet reported, Not yet reported Michael A. Nauck 20 participants Est. completion 2013-12 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT00698932
Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control
Not yet reported AstraZeneca 568 participants Est. completion 2009-10 30 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00713440
Incretin Physiology Associated With Steroid Hormone Treatment
Not yet reported Glostrup University Hospital, Copenhagen 10 participants Est. completion 2009-01 1 siteType 2 diabetes Other conditions: SteroidsView official trial listing → -
Completed NCT NCT00716170
GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia
Herlev Hospital 10 participants Est. completion 2009-07 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00766857
Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure
Not yet reported Amsterdam UMC, location VUmc 27 participants Est. completion 2012-12 1 siteType 2 diabetesHeart failureView official trial listing → -
Completed NCT NCT00768651
Incretin Effect and Use After Clinical Islet Transplantation
Not yet reported University of Alberta 8 participants Est. completion 2011-12 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00770302
Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin
Not yet reported AstraZeneca 34 participants Est. completion 2008-10 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00774488
Acute Effects of Glucose Dependent Insulinotropic Polypeptide (GIP) on Subcutaneous Adipose Tissue
Not yet reported German Institute of Human Nutrition 17 participants Est. completion 2007-07Metabolic syndrome Other conditions: Obesity, Insulin SensitivityView official trial listing → -
Completed NCT NCT00776243
Short-term Effect of Intensive Insulin Therapy on Incretin Secretion
The Catholic University of Korea 30 participants Est. completion 2009-12 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00784745
Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect
Not yet reported University Hospital, Gentofte, Copenhagen 21 participants Est. completion 2009-09 1 siteOther conditions: Insulin Resistance, Glucose IntoleranceView official trial listing → -
Completed NCT NCT00795275
Incretin Effect in People With Impaired Fasting Glucose
Not yet reported University of Colorado, Denver 26 participants Est. completion 2008-11 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT00798915
Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus
Not yet reported Washington University School of Medicine 40 participants Est. completion 2012-12 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT00803296
Incretin Effect in Lean and Obese Subjects
University Hospital, Gentofte, Copenhagen 32 participants Est. completion 2008-06 1 siteType 2 diabetes Other conditions: Incretin Effect, Insulin ResistanceView official trial listing → -
Completed NCT NCT00809874
Effects of Dietary Proteins on Postprandial Lipaemia and Incretin Responses in Obese Subjects
Not yet reported Aarhus University Hospital 11 participants Est. completion 2008-12 1 siteOther conditions: Postprandial Lipaemia, Postprandial Incretins, Postprandial InflammationView official trial listing → -
Completed NCT NCT00817973
Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod Protein
Not yet reported Aarhus University Hospital 12 participants 1 siteType 2 diabetes Other conditions: Postprandial LipemiaView official trial listing → -
Completed NCT NCT00819975
Differential Effects of Milk Proteins on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes
Not yet reported Aarhus University Hospital 12 participants Est. completion 2008-05 1 siteType 2 diabetes Other conditions: Postprandial LipemiaView official trial listing → -
Completed NCT NCT00830076
A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)
Not yet reported Merck Sharp & Dohme LLC 18 participants Est. completion 2009-05-14Type 2 diabetesView official trial listing → -
Completed NCT NCT00832741
Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus
Hvidovre University Hospital 30 participants Est. completion 2008-10 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00843232
Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old
University of Campinas, Brazil 24 participants Est. completion 2010-09 1 siteType 2 diabetes Other conditions: Insulin ResistanceView official trial listing → -
Completed NCT NCT00843479
The Aging Endocrine Pancreas: Characterization of the Entero-insular Axis Physiology in the Elderly
University of Campinas, Brazil 24 participants Est. completion 2010-09 1 siteType 2 diabetes Other conditions: Insulin ResistanceView official trial listing → -
Completed NCT NCT00845182
Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
Not yet reported The University of Texas Health Science Center at San Antonio 43 participants Est. completion 2010-07 1 siteType 2 diabetesPrediabetes Other conditions: HealthyView official trial listing → -
Completed NCT NCT00847080
Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism
Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 20 participants Est. completion 2011-03 1 siteOther conditions: Reactive HypoglycemiaView official trial listing → -
Terminated NCT NCT00853944
Effect of Sitagliptin on Graft Function Following Islet Transplantation
Not yet reported University of British Columbia 12 participants Est. completion 2013-11-01 1 siteOther conditions: Islet TransplantationView official trial listing → -
Completed NCT NCT00856700
Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome
Not yet reported University of Rome Tor Vergata 20 participants Est. completion 2012-06 1 siteMetabolic syndromeView official trial listing → -
Completed NCT NCT00863564
Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects
Not yet reported Aarhus University Hospital 12 participants Est. completion 2009-10 1 siteOther conditions: Obesity, Postprandial Lipemia, Atherosclerosis, Inflammation, Postprandial IncretinsView official trial listing → -
Completed NCT NCT00882492
GLP 1 for Intraoperative Glycemic Control
Not yet reported University of Pennsylvania 80 participants Est. completion 2011-05 1 siteOther conditions: Hyperglycemia, HypoglycemiaView official trial listing → -
Completed NCT NCT00918879
Evaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic Control
Not yet reported AstraZeneca 213 participants Est. completion 2010-07 9 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00939679
Effect of Gastric Bypass Surgery on Energy Metabolism
Not yet reported University of Copenhagen 32 participants Est. completion 2013-04 2 sitesOther conditions: ObesityView official trial listing → -
Completed NCT NCT00940134
Effects of Intravenous Infusions of Gut Hormones on Appetite and Metabolism.
Not yet reported University of Copenhagen 24 participants Est. completion 2012-01 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT00949663
Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function
Not yet reported Washington University School of Medicine 38 participants Est. completion 2014-02 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00951899
The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics
Not yet reported Mayo Clinic 38 participants Est. completion 2012-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00975052
A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 16 participants Est. completion 2006-03Type 2 diabetesView official trial listing → -
Completed NCT NCT00980083
GLP-1 - Regulatory Mechanism of Postprandial Glycemia
Not yet reported Ludwig-Maximilians - University of Munich 12 participants Est. completion 2007-12 1 siteOther conditions: Healthy Subjects, Gastric EmptyingView official trial listing → -
Completed NCT NCT00994435
The Incretin Secretion in the Gut System Related to the Physiological Stimulus
Catholic University of the Sacred Heart 20 participants Est. completion 2011-01 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT00999271
Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid Metabolism
Hvidovre University Hospital 30 participants Est. completion 2009-09 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT01048268
Glucose-dependent Insulinotropic Polypeptide - New Role as Blood Glucose Stabilizer?
Not yet reported, Not yet reported University Hospital, Gentofte, Copenhagen 30 participants Est. completion 2014-04 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT01079624
GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose
Not yet reported Uppsala University 15 participants Est. completion 2009-11 1 siteOther conditions: Physiology, Gastroenterology, EndocrinologyView official trial listing → -
Completed NCT NCT01087372
Stress Hyperglycemia. Potential Role of Incretin Analogs
Hospital Universitari Son Dureta 60 participants Est. completion 2010-04 1 siteOther conditions: Hyperglycemia, Critical IllnessView official trial listing → -
Completed NCT NCT01122641
The Vascular Effects of Vildagliptin in Insulin Resistant Individuals
Not yet reported Royal Devon and Exeter NHS Foundation Trust 15 participants Est. completion 2014-08-01 1 siteOther conditions: Insulin Resistance, Microvascular DiseaseView official trial listing → -
Completed NCT NCT01128829
Sugar-replacement Sweeteners, and Blood Sugar Control
Not yet reported Washington University School of Medicine 17 participants Est. completion 2012-10 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT01173978
Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance
Not yet reported Glostrup University Hospital, Copenhagen 10 participants Est. completion 2010-07 1 siteOther conditions: Insulin Resistance, Deteriorated Glucose Homeostasis, InactivityView official trial listing → -
Completed NCT NCT01232244
Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.
University Hospital, Gentofte, Copenhagen 15 participants Est. completion 2012-01 1 siteOther conditions: Incretin Action, ObesityView official trial listing → -
Completed NCT NCT01234649
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Not yet reported Woman's 153 participants Est. completion 2019-06-14 1 siteType 2 diabetesMetabolic syndromePrediabetes Other conditions: Gestational Diabetes Mellitus, Disorder of Glucose RegulationView official trial listing → -
Terminated NCT NCT01257464
Sitagliptin in Cystic Fibrosis-Related Diabetes
Not yet reported University of British Columbia 3 participants Est. completion 2012-06 1 siteOther conditions: Cystic FibrosisView official trial listing → -
Completed NCT NCT01272583
Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 16 participants Est. completion 2012-10 1 siteOther conditions: Type 1 Diabetes, HypoglycemiaView official trial listing → -
Completed NCT NCT01274052
Study of Postprandial Incretin Response in Women With Gestational Diabetes
University Hospital, Gentofte, Copenhagen 19 participants Est. completion 2008-07 1 siteOther conditions: Gestational Diabetes MellitusView official trial listing → -
Completed NCT NCT01281228
The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
Not yet reported Amsterdam UMC, location VUmc 48 participants Est. completion 2013-10 1 siteType 2 diabetes Other conditions: Diabetes Mellitus, ObesityView official trial listing → -
Completed NCT NCT01296997
Calcium Phosphate and Incretins
Not yet reported University of Jena 10 participants Est. completion 2010-09 1 siteOther conditions: Healthy MenView official trial listing → -
Completed NCT NCT01307995
The Incretin Effect in Patients With Gestational Diabetes Mellitus
Medical University of Lodz 20 participants Est. completion 2010-05 1 siteOther conditions: Gestational DiabetesView official trial listing → -
Completed NCT NCT01327378
The Incretin Effect in Patients With Kidney Impairment
University Hospital, Gentofte, Copenhagen 30 participants Est. completion 2010-10 1 siteOther conditions: Renal Insufficiency, ChronicView official trial listing → -
Completed NCT NCT01342939
Pathophysiological Implications of the Incretin Hormones in Maturity Onset of Diabetes of the Young (MODY)
University Hospital, Gentofte, Copenhagen 31 participants Est. completion 2011-12 1 siteOther conditions: Maturity-onset Diabetes of the YoungView official trial listing → -
Terminated NCT NCT01374568
Changes in Bone Turnover With Increased Incretin Hormone Exposure
Not yet reported University of Alabama at Birmingham 6 participants Est. completion 2015-09 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01375270
Glucolipotoxicity and Type 2 Diabetes
Not yet reported Rigshospitalet, Denmark 30 participants Est. completion 2014-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01391884
Elimination of Incretin Hormones in Patients With Severe Kidney Failure
Bo Feldt-Rasmussen 24 participants Est. completion 2012-06 1 siteOther conditions: UremiaView official trial listing → -
Completed NCT NCT01394952
Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)
Not yet reported Eli Lilly and Company 9901 participants Est. completion 2018-08-21 300 sitesCardiovascular diseaseType 2 diabetesView official trial listing → -
Completed NCT NCT01408862
Effects of Incretins on Human Platelet Function
National Council of Scientific and Technical Research, Argentina 20 participants Est. completion 2014-08Other conditions: Inhibition of Platelet Aggregation by IncretinsView official trial listing → -
Completed NCT NCT01414556
GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes
Not yet reported Mikkel Christensen 12 participants Est. completion 2012-11 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01449019
The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)
Not yet reported Ludwig-Maximilians - University of Munich 24 participants Est. completion 2010-07 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01492283
Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes
University Hospital, Gentofte, Copenhagen 48 participants Est. completion 2014-07 1 siteType 2 diabetes Other conditions: Non Alcoholic Fatty Liver Disease, Liver CirrhosisView official trial listing → -
Completed NCT NCT01503112
Predicting Response to Incretin Based Agents in Type 2 Diabetes
Royal Devon and Exeter NHS Foundation Trust 957 participants Est. completion 2014-04 18 sitesType 2 diabetesView official trial listing → -
Terminated NCT NCT01515059
Analysing Differences in Glycaemic Control Immediately Post Obesity SurgEry (The ADIPOSE Study)
University of Leicester 16 participants Est. completion 2015-12 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT01559779
Effect of Gastric Bypass Surgery on Pancreatic Islets and Incretin Function
Hvidovre University Hospital 11 participants Est. completion 2012-12 1 siteOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT01568125
Effect of Incretin-related Drugs on Dietary Intake in Japanese Patients With Type 2 Diabetes Mellitus
Nagaoka Red Cross Hospital 100 participants Est. completion 2014-01 1 siteType 2 diabetesView official trial listing → -
Withdrawn NCT NCT01573806
Pharmacology of Exenatide in Pediatric Sepsis
Not yet reported, Not yet reported Seattle Children's Hospital Est. completion 2014-10 1 siteOther conditions: Septic Shock, Inflammation, Glucose Homeostasis, Organ Dysfunction, Health-related Quality of LifeView official trial listing → -
Completed NCT NCT01581099
Effect of Bariatric Surgery "Digestive Adaptations III" on Cardiovascular Risk
University of Sao Paulo 30 participants Est. completion 2017-04-20 1 siteMetabolic syndrome Other conditions: Diabetes Mellitus, Obesity, AtherosclerosisView official trial listing → -
Completed NCT NCT01586780
Metabolic Effects of a Pre-meal Protein Drink With or Without Added Amino Acids at a Subsequent Composite Meal
Not yet reported Lund University 14 participants Est. completion 2009-12 1 siteType 2 diabetes Other conditions: Satiety ResponseView official trial listing → -
Completed NCT NCT01607931
Exercise, Glucose Kinetics, and the Incretin Effect
Not yet reported Rigshospitalet, Denmark 12 participants Est. completion 2016-07 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01607944
Incretins and Metabolism
Rigshospitalet, Denmark 20 participants Est. completion 2014-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01650324
A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects
Not yet reported National Health Research Institutes, Taiwan 32 participants Est. completion 2012-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01678742
Effects of Jeju Red Horsehead Fish-based, High Protein Diet on Satiety and Incretin Hormones in Diabetes Patients
Not yet reported Jeju National University Hospital 40 participants Est. completion 2013-04 1 siteOther conditions: Diabetes Mellitus, ObesityView official trial listing → -
Status unknown NCT NCT01681550
A Cohort Study of Incretin-based Therapy Combined With Insulin in Type 2 Diabetic Patients for 5 Years
Not yet reported Nagaoka Red Cross Hospital 500 participants Est. completion 2018-10 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01682343
Effect of High-calcium Intake on Appetite, Insulinemia and Incretins
Not yet reported Northumbria University 10 participants Est. completion 2012-08 1 siteOther conditions: Nutritional and Metabolic DiseasesView official trial listing → -
Completed NCT NCT01698502
Physical Training and the Incretin Effect
University of Copenhagen 21 participants Est. completion 2013-06 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01708681
Lean Seafood Intake and Postprandial Metabolism
Not yet reported National Institute of Nutrition and Seafood Research, Norway 27 participants Est. completion 2015-09 1 siteOther conditions: Hyperlipidemias, Nutritional and Metabolic Diseases, Nutrition Disorders, Metabolic Diseases, Glucose Metabolism DisordersView official trial listing → -
Completed NCT NCT01721382
Treatment of Dysglycemia Using Sitagliptin in Adolescents With Cystic Fibrosis
Not yet reported Nemours Children's Clinic 6 participants Est. completion 2016-06 1 siteOther conditions: Cystic FibrosisView official trial listing → -
Completed NCT NCT01744236
SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
Not yet reported Amsterdam UMC, location VUmc 70 participants Est. completion 2015-08 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01749163
Hyperglycemia and the Extra-pancreatic Effect of Incretins
Not yet reported Rigshospitalet, Denmark 20 participants Est. completion 2014-03 1 siteOther conditions: Extra-pancreatic Incretin Effect, Glucose EffectivenessView official trial listing → -
Status unknown NCT NCT01758471
Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes
Not yet reported Shanghai Jiao Tong University School of Medicine 160 participants Est. completion 2014-06 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01779622
Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin Hormone Secretion in Healthy Volunteers
Not yet reported Lund University 24 participants Est. completion 2014-06 1 siteOther conditions: Healthy Volunteers Recruited From the General PopulationView official trial listing → -
Completed NCT NCT01782261
Incretin Effect on the Immunological Phenotype
Not yet reported Medical University of Graz 15 participants Est. completion 2015-02 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT01795144
Incretin Regulation of Insulin Secretion in Monogenic Diabetes
Not yet reported University of Chicago 10 participants Est. completion 2017-03 1 siteOther conditions: Monogenic DiabetesView official trial listing → -
Completed NCT NCT01795248
The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes
Not yet reported Tina Vilsboll 105 participants Est. completion 2020-09 1 siteOther conditions: Gestational Diabetes MellitusView official trial listing → -
Completed NCT NCT01800188
Glucose Metabolism During Hemodialysis
Bo Feldt-Rasmussen 10 participants 1 siteOther conditions: ESRDView official trial listing → -
Status unknown NCT NCT01800734
Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study
Not yet reported Azienda Ospedaliera Universitaria Integrata Verona 20 participants Est. completion 2015-02 1 siteOther conditions: Diabetes Mellitus Type 1View official trial listing → -
Completed NCT NCT01806506
Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity
Not yet reported Medical University of Warsaw 72 participants Est. completion 2013-11 1 siteMetabolic syndrome Other conditions: Morbid Obesity, Diabetes Mellitus, Dyslipidemia, HypertensionView official trial listing → -
Withdrawn NCT NCT01820273
Changes in Incretins Response and Glycemic Control After Gastric Bypass Surgery in Type 2 Diabetic Patients Versus Healthy
Lund University Est. completion 2019-08-01 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT01827280
Acute and Short-term Chronic Effects of Galvus (Vildagliptin) in Diabetes Type 2 Obese Women
Not yet reported Rio de Janeiro State University 40 participants Est. completion 2016-11 1 siteOther conditions: 1- Microvascular Function, 2-oxidative Stress, 3-inflammationView official trial listing → -
Completed NCT NCT01834404
Peripheral Pharmacodynamics of Phentermine-Topiramate in Obese Patients
Not yet reported Mayo Clinic 24 participants Est. completion 2014-03 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT01843855
The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass
Not yet reported Adrian Vella 12 participants Est. completion 2013-09 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01843881
The Contribution of Incretin Hormones to Post-prandial Glucose Metabolism After Roux-en-Y Gastric Bypass
Not yet reported Adrian Vella 20 participants Est. completion 2013-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01879228
Effect of Chronic Incretin-based Therapy in Cystic Fibrosis
Not yet reported University of Pennsylvania 26 participants Est. completion 2020-03 1 siteOther conditions: Cystic Fibrosis, Pancreatic InsufficiencyView official trial listing → -
Completed NCT NCT01880827
Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery
Not yet reported Turku University Hospital 36 participants Est. completion 2016-01 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT01892254
Incretin Effect in PCOS Women
Not yet reported University Hospital, Gentofte, Copenhagen 20 participants Est. completion 2017-11-23 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT01919489
Liraglutide Hospital Discharge Trial
Not yet reported Emory University 273 participants Est. completion 2020-08-30 5 sites Stand-aloneType 2 diabetesView official trial listing → -
Withdrawn NCT NCT01930448
Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1
St. Luke's-Roosevelt Hospital Center Est. completion 2014-09 1 siteType 2 diabetes Other conditions: Gastric Bypass Surgery, Gastric BandingView official trial listing → -
Terminated NCT NCT01934816
Incretin and KATP Channels
Not yet reported Katarina Kos 2 participants Est. completion 2015-10 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT01937598
Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
Not yet reported Michael A. Nauck 16 participants Est. completion 2015-06 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01938469
Effect of Meal Number, Frequency, and Form on Satiety and Metabolism After Weight Loss Surgery
Not yet reported St. Luke's-Roosevelt Hospital Center 33 participants Est. completion 2014-07 1 siteOther conditions: Gastric Bypass Surgery, ObesityView official trial listing → -
Completed NCT NCT01966978
The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
Not yet reported University of Texas Southwestern Medical Center 157 participants Est. completion 2017-12 1 siteType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT01969149
Exenatide for Stress Hyperglycemia
Not yet reported, Not yet reported Centre Hospitalier Universitaire de Besancon 110 participants Est. completion 2016-12 1 siteOther conditions: Stress HyperglycemiaView official trial listing → -
Completed NCT NCT01975259
Investigating the Incretin Effect in Cystic Fibrosis
Liverpool Heart and Chest Hospital NHS Foundation Trust 50 participants Est. completion 2015-07 1 siteOther conditions: Cystic FibrosisView official trial listing → -
Status unknown NCT NCT02003274
Mixed Meal Test in Type 1 Diabetes on Insulin Pump Therapy: Optimization of Artificial Pancreas
Not yet reported Azienda Ospedaliera Universitaria Integrata Verona 20 participants Est. completion 2017-10-31 2 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Status unknown NCT NCT02005978
Brain-gut Interaction in Irradiated Patients With Acromegaly
Rigshospitalet, Denmark 36 participants Est. completion 2017-12 1 siteOther conditions: AcromegalyView official trial listing → -
Completed NCT NCT02006459
Involvement of Extrapancreatic Factors on Gastrointestinal-mediated Glucose Disposal
University Hospital, Gentofte, Copenhagen 20 participants Est. completion 2015-10 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT02010827
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
University Hospital, Gentofte, Copenhagen 20 participants Est. completion 2015-08 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02021903
Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies
Not yet reported University Hospital, Toulouse 21 participants Est. completion 2020-06 2 sites Stand-aloneOther conditions: Parkinsonian DisordersView official trial listing → -
Completed NCT NCT02026024
Incretin Based Therapy for Poorly Controlled Type 2 Diabetic Patients
Chang Gung Memorial Hospital 10 participants Est. completion 2015-12 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT02029846
Glycemia in Diabetic Elders Trial
Not yet reported Johns Hopkins University 2 participants Est. completion 2017-02 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02036138
The Efficacy of Bariatric Surgery Compared to Medical Therapy in Controlling Type2 Diabetes Mellitus in Patients With Non Morbid Obesity.
Not yet reported, Not yet reported Hadassah Medical Organization 76 participants Est. completion 2019-07 1 siteOther conditions: Overweight, Diabetes Type 2View official trial listing → -
Completed NCT NCT02039986
Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF)
Children's Hospital of Philadelphia 13 participants Est. completion 2016-10-11 1 siteOther conditions: Cystic Fibrosis Related Diabetes, Cystic FibrosisView official trial listing → -
Completed NCT NCT02041234
Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment
Not yet reported Khoo Teck Puat Hospital 40 participants Est. completion 2022-06 1 siteOther conditions: Type II Diabetes in Subjects BMI 27 to 32View official trial listing → -
Status unknown NCT NCT02055014
Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)
Not yet reported Sandwell & West Birmingham Hospitals NHS Trust 72 participants Est. completion 2017-03 4 sitesType 2 diabetes Other conditions: Obesity, DiabesityView official trial listing → -
Completed NCT NCT02060383
Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
Not yet reported Novartis Pharmaceuticals 249 participants Est. completion 2018-03-26 43 sitesOther conditions: Cushing's Disease, AcromegalyView official trial listing → -
Completed NCT NCT02089438
DPP-4 Inhibition, Incretins and Islet Function
Not yet reported Lund University 24 participants Est. completion 2017-08 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02092896
Liraglutide as add-on to Insulin in Type 1 Diabetes
Not yet reported Hvidovre University Hospital 40 participants Est. completion 2014-10 1 siteOther conditions: Diabetes, Diabetes Mellitus, Type 1View official trial listing → -
Status unknown NCT NCT02126592
The Secretion of Incretin Hormones in Patients With Polycystic Ovary Syndrome
RenJi Hospital 100 participants Est. completion 2014-05 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT02134860
Bed Rest, Alternate Daily Fasting and Incretin Effect
Not yet reported Rigshospitalet, Denmark 20 participants Est. completion 2014-09 1 siteMetabolic syndromeType 2 diabetes Other conditions: Critical IllnessView official trial listing → -
Completed NCT NCT02161666
Effect of Gastric Bypass Surgery on Pancreatic Islet and Incretin Function - Follow-up Study
Hvidovre University Hospital 7 participants Est. completion 2014-12 1 siteOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT02162550
Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
Not yet reported Phoenix VA Health Care System 148 participants Est. completion 2019-09 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02163278
A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects
Not yet reported National Health Research Institutes, Taiwan 32 participants Est. completion 2015-01 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02175459
Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 100 participants Est. completion 2024-12 1 siteOther conditions: GLUCOSE METABOLISM, DIABETES, PANCREATIC ISLETS, Exocrine Pancreatic Dysfunction, Exocrine Pancreas Conditions, Exocrine Pancreatic Insufficiency, Endocrine Pancreas DisorderView official trial listing → -
Completed NCT NCT02180334
The Effect of Combination of Mosapride and DPP-4 Inhibitor on Plasma Concentration of Incretin Hormones
Not yet reported Seoul National University Hospital 12 participants Est. completion 2015-04 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02180646
Impact of Breakfast Composition on Glycemic and Incretin Responses in Individuals With Type 2 Diabetes
Not yet reported University of Missouri-Columbia 12 participants Est. completion 2013-04Type 2 diabetesView official trial listing → -
Completed NCT NCT02195856
Effects of Nitrate on Liver Perfusion and Sugar Control
Not yet reported University of Exeter 31 participants Est. completion 2017-07-20 2 sitesType 2 diabetes Other conditions: AgeingView official trial listing → -
Completed NCT NCT02203240
Cocoa and Metabolic Health in Prediabetes
Not yet reported Virginia Polytechnic Institute and State University 16 participants Est. completion 2016-05 1 sitePrediabetesView official trial listing → -
Completed NCT NCT02219295
SEGATROM: Sensory and Gastrointestinal Impact of Taste Receptor Variants on Human Metabolism and Nutrition
Not yet reported German Institute of Human Nutrition 97 participants Est. completion 2014-09 1 site Stand-aloneOther conditions: Disorder of Glucose RegulationView official trial listing → -
Completed NCT NCT02234349
Bile Acids and Incretins in Pancreas Kidney Transplant Patients
Not yet reported Hospices Civils de Lyon 50 participants Est. completion 2017-03-23 1 siteOther conditions: Pancreas-kidney Transplantation, Kidney TransplantationView official trial listing → -
Completed NCT NCT02235584
Insulinotropic Effect of GLP-1 and GIP After Dexamethasone
Not yet reported Hvidovre University Hospital 19 participants 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02237521
The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease
Bo Feldt-Rasmussen 24 participants Est. completion 2016-04-28 1 siteOther conditions: End-stage Renal DiseaseView official trial listing → -
Completed NCT NCT02256189
Sitagliptin and Glucagon Counterregulation
Not yet reported Lund University 28 participants Est. completion 2017-06 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02297074
Evaluation of Glycemic Index, Glycemic Load and Insulinemic Index of Spanish Breads
Not yet reported Organización Interprofesional Agroalimentaria de Cereales Panificables y Derivados 22 participants Est. completion 2013-08Other conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT02308254
Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People
Not yet reported, Not yet reported Royal Adelaide Hospital 30 participants Est. completion 2016-04 1 siteOther conditions: Diabetes Mellitus, GastroparesisView official trial listing → -
Completed NCT NCT02324010
Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes
Not yet reported Royal Adelaide Hospital 14 participants Est. completion 2017-01 1 siteOther conditions: Gastroparesis, Diabetes MellitusView official trial listing → -
Completed NCT NCT02324842
Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
Not yet reported The University of Texas Health Science Center at San Antonio 45 participants Est. completion 2019-03-31 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02360878
The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin Hormones
Filip Krag Knop 25 participants Est. completion 2017-07 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT02363335
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Not yet reported National Institute on Aging (NIA) 29 participants Est. completion 2016-09-19 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT02370745
Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle
Not yet reported University of Nottingham 40 participants Est. completion 2018-03 1 siteOther conditions: SarcopeniaView official trial listing → -
Completed NCT NCT02420392
Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell
Not yet reported Seoul National University Hospital 30 participants Est. completion 2016-04 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02432976
Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients
Not yet reported, Not yet reported Centre Hospitalier Universitaire de Besancon 64 participants Est. completion 2017-01 1 siteOther conditions: Quality of LifeView official trial listing → -
Completed NCT NCT02456428
Incretin-based Drugs and the Risk of Heart Failure
Canadian Network for Observational Drug Effect Studies, CNODES 1499650 participants Est. completion 2015-05 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02459535
Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 1
Not yet reported German Institute of Human Nutrition 14 participants Est. completion 2019-07 1 sitePrediabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT02475499
Incretin-based Drugs and Pancreatic Cancer
Canadian Network for Observational Drug Effect Studies, CNODES 886172 participants Est. completion 2015-04 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02476760
Incretin-based Drugs and Acute Pancreatitis
Canadian Network for Observational Drug Effect Studies, CNODES 1417914 participants Est. completion 2015-04 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02487537
Immediate and Long-term Induction of Incretin Release by Artificial Sweeteners 2
Not yet reported German Institute of Human Nutrition 10 participants Est. completion 2019-07 1 sitePrediabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT02497651
Effect of Smoking on Postprandial Gastric Emptying, Glucose Tolerance and Secretion of Gut and Pancreatic Hormones
Not yet reported University Hospital, Gentofte, Copenhagen 24 participants Est. completion 2016-06 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Status unknown NCT NCT02503943
Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
Not yet reported Third Affiliated Hospital of Third Military Medical University 90 participants Est. completion 2016-09Type 2 diabetes Other conditions: Overweight, Obesity, Masked HypertensionView official trial listing → -
Completed NCT NCT02539641
Bariatric Procedures and Changes in Incretins and Gastric Emptying
Not yet reported Rijnstate Hospital 32 participants Est. completion 2016-05 1 siteOther conditions: Morbid ObesityView official trial listing → -
Completed NCT NCT02550548
Incretin Action in Physiology and Diabetes
Not yet reported David D'Alessio, M.D. 39 participants Est. completion 2021-04-16 1 siteOther conditions: Insulin SecretionView official trial listing → -
Status unknown NCT NCT02584582
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
Not yet reported, Not yet reported Hvidovre University Hospital 10 participantsOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT02589028
The Effects of Premeal Consumption of Protein-enriched Bar on Blood Glucose Level and Secretion of Hormones
Not yet reported Seoul National University Hospital 30 participants Est. completion 2016-09 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT02598791
GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake
Not yet reported University Hospital, Gentofte, Copenhagen 18 participants Est. completion 2016-06-20 1 siteType 2 diabetes Other conditions: Obesity, AdiposityView official trial listing → -
Status unknown NCT NCT02611232
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
Not yet reported University of Oulu 42 participants Est. completion 2024-06 3 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Status unknown NCT NCT02637388
Effects of Beta-glucan on Energy Intake and Satiety
Not yet reported Queen Margaret University 36 participants Est. completion 2016-12 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT02639130
GLP-1 Mediating DPP-4 Inhibition in Type 2 Diabetes
Not yet reported Diabeteszentrum Bad Lauterberg im Harz 67 participants Est. completion 2010-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02650947
Sucralose Effects on Glucose Metabolism and Gut Microbiota
Not yet reported Ramathibodi Hospital 15 participants Est. completion 2017-04 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02669524
Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes
Not yet reported University Hospital, Gentofte, Copenhagen 20 participants Est. completion 2016-08 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02671864
Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy
Not yet reported Assistance Publique - Hôpitaux de Paris 7200 participants Est. completion 2025-04-11 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT02673554
The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP
Not yet reported Diabeteszentrum Bad Lauterberg im Harz 30 participantsType 2 diabetesView official trial listing → -
Terminated NCT NCT02674893
Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes
Not yet reported Centre Hospitalier Universitaire Dijon 48 participants Est. completion 2016-08-31 1 siteType 2 diabetes Other conditions: OverweightView official trial listing → -
Completed NCT NCT02694575
The Impact of Glucose Lowering Therapies on Circulating Endothelial Progenitor Cells and Its Mobilising Factor Stromal Derived Factor-1α in Patients With Type 2 Diabetes
University of Leicester 241 participants Est. completion 2018-08-31 1 siteType 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02697305
Incretin Effects of Branched Chain Amino Acids
Not yet reported Charles University, Czech Republic 18 participants Est. completion 2015-12 1 siteOther conditions: Glucose Metabolism DisordersView official trial listing → -
Status unknown NCT NCT02723110
Defining the Physiological Mechanisms of Risk Genes for Hyperglycaemia, Insulin Resistance and Type 2 Diabetes
University of Oxford 40 participants Est. completion 2016-07 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02725502
Incretin Axis in Type 1 Diabetes Mellitus
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 20 participants Est. completion 2016-05 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT02733588
Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients
Not yet reported Xeris Pharmaceuticals 8 participants Est. completion 2017-06-01 1 siteOther conditions: Hypoglycemia, Complications of Bariatric ProceduresView official trial listing → -
Completed NCT NCT02762708
The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes
Not yet reported Mayo Clinic 12 participants Est. completion 2018-01-06 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT02779075
Exendin-9,39 and Satiety After Bariatric Surgery
Not yet reported Mayo Clinic 29 participants Est. completion 2019-12 1 siteOther conditions: ObesityView official trial listing → -
Terminated NCT NCT02844907
Regulation of Insulin Secretion by the GLP-1 Receptor
Not yet reported VA Office of Research and Development 6 participants Est. completion 2021-12-31 1 siteOther conditions: Insulin SecretionView official trial listing → -
Completed NCT NCT02845557
Glucose Homeostasis and Incretin Effect T2DM in the Youth- a Study of the Malaysian Population
RCSI & UCD Malaysia Campus 48 participants Est. completion 2014-12 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02882477
Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
Not yet reported, Not yet reported Hadassah Medical Organization 20 participants Est. completion 2018-12 1 siteOther conditions: Diabetes Mellitus, Iron Metabolism Disorders, Gastroduodenal Ulcer, Optic Atrophy, Sensorineural Hearing Loss, Platelet DysfunctionView official trial listing → -
Completed NCT NCT02898506
Incretin-based Therapy in Late Preclinical Type 1 Diabetes
Not yet reported University of Oulu 13 participants Est. completion 2021-06 4 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT02908087
Incretin-based Therapy in Early Diagnosed Type 1 Diabetes
Not yet reported University of Oulu 13 participants Est. completion 2021-05 4 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT02921906
Effect of Food Composition on Postprandial Insulin Secretion in Neonatal Diabetes
Not yet reported Royal Devon and Exeter NHS Foundation Trust 16 participants Est. completion 2022-06-20 1 siteOther conditions: Neonatal DiabetesView official trial listing → -
Completed NCT NCT03017352
Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
Not yet reported Filip Krag Knop 108 participants Est. completion 2019-06 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03062592
FFAR Agonist on Incretins, Insulin, Lipids and Inflammation
Not yet reported Odense University Hospital 8 participants Est. completion 2016-04Type 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT03081676
The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea
Not yet reported University Hospital, Gentofte, Copenhagen 20 participants Est. completion 2018-06-01 1 siteOther conditions: Maturity-Onset Diabetes of the Young, Type 3View official trial listing → -
Completed NCT NCT03103009
Treatment Plan for an Individual Patient With Pasireotide for Hyperinsulinemic Hypoglycemia
Not yet reported University of Colorado, Denver 1 participants Est. completion 2017-12-22 1 siteOther conditions: Hyperinsulinemic Hypoglycemia, Post Gastrointestinal Tract Surgery HypoglycaemiaView official trial listing → -
Completed NCT NCT03169959
A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.
Not yet reported AstraZeneca 85 participants Est. completion 2017-08-03 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT03195257
Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes
Not yet reported Mikkel Christensen 10 participants Est. completion 2016-12-01Other conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03204877
Acute Metabolic Effects of Melatonin Treatment
Not yet reported, Not yet reported University of Aarhus 36 participants Est. completion 2020-02-01 1 siteOther conditions: Glucose Metabolism DisordersView official trial listing → -
Status unknown NCT NCT03230123
Effects of Green Banana BIOmass Consumption in Patients With Pre-diabetes and Diabetes MELlitus (The BIOMEL Study)
Not yet reported Federal University of São Paulo 136 participants Est. completion 2018-06 1 sitePrediabetes Other conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT03282136
SGLT2i and Incretin and CRTd.
Not yet reported University of Campania Luigi Vanvitelli 500 participants Est. completion 2024-09-01 1 siteType 2 diabetesHeart failureView official trial listing → -
Completed NCT NCT03305367
Dose-response Effect of Pine Nut Oil as a Dual FFA1 and FFA4 Agonist on Glucose Tolerance in Healthy Humans.
Not yet reported Odense University Hospital 10 participants Est. completion 2017-08-23 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT03305783
The Influence of Cholecystectomy on Secretion of Incretin Hormones
University Hospital, Gentofte, Copenhagen 40 participants Est. completion 2022-04-01 1 siteOther conditions: Glucose Metabolism DisordersView official trial listing → -
Completed NCT NCT03312179
STEMI and Incretins Treatment
University of Campania Luigi Vanvitelli 900 participants Est. completion 2017-10-01 1 siteCardiovascular disease Other conditions: STEMI, Coronary Syndrome, Coronary Arteriosclerosis, DiabetesView official trial listing → -
Completed NCT NCT03348371
The Effects of Ethanol on Intestinal Permeability and Gut Hormones
Not yet reported University of Copenhagen 12 participants Est. completion 2017-10-01Other conditions: Insulin Resistance, Ethanol, Incretin EffectView official trial listing → -
Completed NCT NCT03360981
Epicardial Fat and Clinical Outcomes After Coronary Artery Bypass Grafting in Diabetics vs. Non Diabetics
Not yet reported University of Campania Luigi Vanvitelli 150 participants Est. completion 2025-08-20 1 siteCardiovascular disease Other conditions: DiabetesView official trial listing → -
Enrolling by invitation NCT NCT03407833
Physiologic and Functional Adaptations of Insulin Sensitive Tissues
Vanderbilt University Medical Center 500 participants Est. completion 2028-02 1 siteOther conditions: Diabetes, Insulin Resistance, Obesity, Bariatric Surgery Candidate, Roux-en-y Gastric Bypass, Liver DiseasesView official trial listing → -
Completed NCT NCT03454087
Study of Early Enteral Dextrose in Sepsis
Not yet reported University of Pittsburgh 58 participants Est. completion 2020-04-01 1 siteOther conditions: SepsisView official trial listing → -
Completed NCT NCT03486964
Use of Incretins in Diabetic Patients
University of Pavia 2234 participants Est. completion 2021-05-30 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT03537235
Evaluation of Libramed in Obesity Treatment
Not yet reported Aboca Spa Societa' Agricola 40 participants Est. completion 2019-02-22 1 siteOther conditions: Overweight and ObesityView official trial listing → -
Completed NCT NCT03556098
Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 Diabetes
Not yet reported Steno Diabetes Center Copenhagen 12 participants Est. completion 2020-02-11 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03574064
Effects of Gut Peptides on Bone Remodeling
Not yet reported University of Copenhagen 10 participants Est. completion 2019-01-01 1 siteOther conditions: HealthyView official trial listing → -
Terminated NCT NCT03608358
Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin
Not yet reported AstraZeneca 41 participants Est. completion 2020-08-04 4 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT03609632
Understanding Hypoglycaemia After Bariatric Surgery
Not yet reported Insel Gruppe AG, University Hospital Bern 16 participants Est. completion 2018-11-02 1 siteOther conditions: Bariatric SurgeryView official trial listing → -
Withdrawn NCT NCT03644199
Development of Diabetes in Adults With Cystic Fibrosis (CF)
Not yet reported Liverpool Heart and Chest Hospital NHS Foundation Trust Est. completion 2017-08-30 1 siteOther conditions: Cystic FibrosisView official trial listing → -
Completed NCT NCT03659461
Glucagon-like Peptide-1 Levels, Insulin Resistance and Insulin Sensitivity Index in Type 2 Diabetes Mellitus
Not yet reported National University of Malaysia 174 participants Est. completion 2020-01-31 1 siteType 2 diabetesPrediabetesView official trial listing → -
Completed NCT NCT03680482
To Compare the Effects of Non-nutritive Sweeteners Intake in Subjects With T2DM
Not yet reported University of Chile 17 participants Est. completion 2017-08-31Type 2 diabetesView official trial listing → -
Completed NCT NCT03705195
Study of Sulphonylurea Synergy With Incretins
Not yet reported University of Dundee 20 participants Est. completion 2019-06-26 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT03713502
Enteropathy and Diabetes in HIV Patients
National Institute for Medical Research, Tanzania 1947 participants Est. completion 2022-12-30 1 siteOther conditions: Diabetes, Environmental Enteropathy, HIVView official trial listing → -
Completed NCT NCT03714594
Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.
Not yet reported University of Pisa 48 participants Est. completion 2022-08-31 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT03725969
Effect of Camel Milk on Insulin and Incretin Response
Not yet reported Imperial College London Diabetes Centre 15 participants Est. completion 2020-12-30 1 siteOther conditions: Insulin Sensitivity, Glucose ToleranceView official trial listing → -
Completed NCT NCT03734718
The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes
Not yet reported Steno Diabetes Center Copenhagen 20 participants Est. completion 2019-12-31 1 siteOther conditions: Diabetes Mellitus, Type 1, HypoglycemiaView official trial listing → -
Completed NCT NCT03770910
The Effect of GIP(3-30)NH2
Not yet reported University Hospital, Gentofte, Copenhagen 8 participants Est. completion 2019-12-01 2 sitesOther conditions: Endocrine - OtherView official trial listing → -
Status unknown NCT NCT03774095
Effect of Dietary Oils as G-protein-coupled Receptor Agonists on Glucose Tolerance
Not yet reported Karina Vejrum Sørensen 10 participants Est. completion 2018-12-30 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT03779048
Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral Treatment
Not yet reported University of Pennsylvania 147 participants Est. completion 2022-05-25 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT03806920
Isomaltulose VS Sucrose - Postprandial Effect on Incretin Profile and Second Meal Effect
Not yet reported German Institute of Human Nutrition 50 participants Est. completion 2019-07-30 1 siteType 2 diabetesMetabolic syndromeView official trial listing → -
Completed NCT NCT03829800
Formulas for Diabetes With Sucromalt & Isomaltulose on Glycemic Index, Hormones & Subjective Appetite in Type 2 Diabetes
Not yet reported Universidad del Zulia 23 participants Est. completion 2018-11-15Type 2 diabetesView official trial listing → -
Completed NCT NCT03860623
Effect of Oral Feeding on Gastric Emptying, Gut Blood Flow, and Hormone Responses in Obese and Healthy Weight Subjects
University of Nottingham 20 participants Est. completion 2022-10-28 1 siteOther conditions: ObesityView official trial listing → -
Terminated NCT NCT03866421
NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney Transplantation
Rigshospitalet, Denmark 3 participants Est. completion 2022-03-31 1 siteChronic kidney diseasePrediabetes Other conditions: Non-Alcoholic Fatty Liver Disease, Kidney TransplantView official trial listing → -
Completed NCT NCT03919877
Precision Diets for Diabetes Prevention
Not yet reported Stanford University 115 participants Est. completion 2023-10-18 1 siteType 2 diabetes Other conditions: Pre Diabetes, Insulin ResistanceView official trial listing → -
Completed NCT NCT03950245
Incretin Hormone Antagonism After Bariatric Surgery
Not yet reported Hvidovre University Hospital 36 participants Est. completion 2021-04-16 2 sitesOther conditions: Bariatric SurgeryView official trial listing → -
Status unknown NCT NCT03965000
Human Solute Carrier Family 5 Member 2 (SLC5A2) Deficiency and the Glucagon-Incretin Axis
Medical University Innsbruck 10 participants Est. completion 2022-01 1 siteCardiovascular disease Other conditions: Familial Renal Glucosuria, Diabetes MellitusView official trial listing → -
Terminated NCT NCT03966261
The Role of Incretins in Bone Remodeling in Humans
University Hospital, Angers 104 participants Est. completion 2022-05-02 1 siteOther conditions: Incretins, Osteoporosis, Bone Remodeling, HealthyView official trial listing → -
Status unknown NCT NCT04146155
Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 200 participants Est. completion 2021-12-31 1 siteType 2 diabetes Other conditions: Peripheral Vascular Disorder Due to Diabetes MellitusView official trial listing → -
Status unknown NCT NCT04177303
Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment
Not yet reported Hellenic Institute for the Study of Sepsis 44 participants Est. completion 2022-11-29 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT04192292
Study of Sulphonylurea Synergy With DPP4 Inhibitors
Not yet reported University of Dundee 30 participants Est. completion 2020-12-02 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT04228484
The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes
Not yet reported University Hospital, Gentofte, Copenhagen 15 participants Est. completion 2022-10-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT04255433
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
Not yet reported Eli Lilly and Company 13299 participants Est. completion 2025-06-12 635 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT04299815
Lactate in the Gut
Not yet reported University of Aarhus 10 participants Est. completion 2020-07-29 1 siteOther conditions: Lactate, Healthy, HyperlactatemiaView official trial listing → -
Completed NCT NCT04347252
Glucagon Regulation of Glucose Metabolism
Not yet reported David D'Alessio, M.D. 19 participants Est. completion 2021-04-16 1 siteOther conditions: Insulin SecretionView official trial listing → -
Status unknown NCT NCT04535960
Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial
Not yet reported University Health Network, Toronto 36 participants Est. completion 2023-10 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT04626323
Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease
Not yet reported Hospital Alemão Oswaldo Cruz 60 participants Est. completion 2024-12 1 siteType 2 diabetes Other conditions: Kidney Disease, Chronic, Kidney InjuryView official trial listing → -
Completed NCT NCT04698889
Effect of Ingestion of Human, Cow, and Modified-cow Milk, on Glucose and Hormone Responses in Humans.
Not yet reported University of Padova 17 participants Est. completion 2020-10-01Other conditions: Insulin Tolerance, Hormone, AminoacidaemiaView official trial listing → -
Completed NCT NCT04782999
Effect of RYGB on Alpha- and Beta Cell Function and Sensitivity to Incretins in Patients With Type 2 Diabetes
Not yet reported Hvidovre University Hospital 9 participants Est. completion 2022-03 1 siteType 2 diabetes Other conditions: Obesity, MorbidView official trial listing → -
Completed NCT NCT04881760
A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
Not yet reported Eli Lilly and Company 338 participants Est. completion 2022-11-22 28 sitesOther conditions: Obesity, OverweightView official trial listing → -
Completed NCT NCT04889859
Impact of Biliopancreatic Limb Length on Diabetes Following Distal Gastrectomy
Not yet reported Kyungpook National University Chilgok Hospital 30 participants Est. completion 2023-02-28 1 siteType 2 diabetes Other conditions: Stomach NeoplasmView official trial listing → -
Completed NCT NCT05078255
The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 Diabetes
Not yet reported Asger Lund, MD 61 participants Est. completion 2025-01-24 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT05154461
Intestinal Ketone Bodies Interfere With the Glycemic Control
Not yet reported Göteborg University 8 participants Est. completion 2022-09-01 1 siteOther conditions: Healthy Adult VolunteersView official trial listing → -
Completed NCT NCT05162014
To Assess the Risk of Acute Pancreatitis in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin
Boehringer Ingelheim 494679 participants Est. completion 2022-09-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT05177653
Separate and Combined Extrapancreatic Effects of the Incretin Hormones
Not yet reported University Hospital, Gentofte, Copenhagen 13 participants Est. completion 2023-03-03 1 siteOther conditions: Pancreatectomy; HyperglycemiaView official trial listing → -
Completed NCT NCT05260021
A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
Not yet reported Eli Lilly and Company 99 participants Est. completion 2025-01-28 51 sitesType 2 diabetes Other conditions: Diabetes Mellitus, Glucose Metabolism Disorders, Endocrine System Diseases, Metabolic DiseaseView official trial listing → -
Completed NCT NCT05306613
Breaking Sitting and Metabolic Health in Sedentary Lean Adults
Not yet reported National Taiwan Normal University 13 participants Est. completion 2023-03-01 1 siteOther conditions: Metabolic Health, Gut Hormones, Energy BalanceView official trial listing → -
Completed NCT NCT05306678
Breaking Sitting and Metabolic Health in Sedentary Overweight and Obese Adults
Not yet reported National Taiwan Normal University 13 participants Est. completion 2023-03-01 1 siteOther conditions: Metabolic Health, Gut Hormones, Energy BalanceView official trial listing → -
Status unknown NCT NCT05446415
L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP
Not yet reported University of Sao Paulo General Hospital 20 participants Est. completion 2022-12-05 1 siteType 2 diabetes Other conditions: Severe ObesityView official trial listing → -
Completed NCT NCT05570435
Efficacy of Milk Product Supplemented With Bioactives in Lowering Post Meal Glucose Response
Not yet reported Société des Produits Nestlé (SPN) 31 participants Est. completion 2023-03-14 1 sitePrediabetes Other conditions: Healthy, Adult, AsianView official trial listing → -
Status unknown NCT NCT05654805
Nutraceutical Improvement of Glucose Metabolism, NAFLD and Insulin Resistance by Oat-fiber Supplementation in Type 2 Diabetes Mellitus Patients
Not yet reported Charite University, Berlin, Germany 92 participants Est. completion 2024-10 1 siteType 2 diabetesMASLDView official trial listing → -
Status unknown NCT NCT05829018
Elucidating the High Cardiovascular Disease Risk in South Asians
Not yet reported Leiden University Medical Center 48 participants Est. completion 2024-06 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT05947370
Berberine on the Secretion of Incretin
Not yet reported Beijing Tongren Hospital 16 participants Est. completion 2023-04-20 2 sitesOther conditions: Diabetes MellitusView official trial listing → -
Active, not recruiting NCT NCT06037252
A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
Not yet reported Eli Lilly and Company 414 participants Est. completion 2026-10 40 sitesType 2 diabetes Other conditions: ObesityView official trial listing → -
Enrolling by invitation NCT NCT06043245
Diabetes Remission and Hypoabsorptive Bariatric Surgery
Not yet reported Hospital Universitari de Bellvitge 66 participants Est. completion 2027-09-30 1 siteType 2 diabetes Other conditions: Severe Obesity, Bariatric Surgery CandidateView official trial listing → -
Completed NCT NCT06064084
Incretin Effect in Patients With Psoriasis and Controls
University Hospital, Gentofte, Copenhagen 24 participants Est. completion 2015-09-11Other conditions: Psoriasis VulgarisView official trial listing → -
Completed NCT NCT06094894
Effects of Sucralose in Gut Intestinal Microbiota and Postprandial GLP-1
Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 40 participants Est. completion 2024-03-01 1 siteOther conditions: GLP-1, Gut Microbiota, Insulin ResistanceView official trial listing → -
Completed NCT NCT06124807
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
Not yet reported Eli Lilly and Company 179 participants Est. completion 2025-07-09 29 sitesOther conditions: Obesity, Overweight and ObesityView official trial listing → -
Completed NCT NCT06137586
The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Patients with Type 1 Diabetes
Not yet reported University Hospital, Gentofte, Copenhagen 10 participants Est. completion 2024-05-17 1 siteOther conditions: Type1diabetes, Hypoglycemia, Type 1 DiabetesView official trial listing → -
Completed NCT NCT06143267
Neuronostatin - a Glucagonotropic Agent in Humans?
Not yet reported University Hospital, Gentofte, Copenhagen 10 participants Est. completion 2024-09-25 1 siteOther conditions: Type 1 Diabetes, Hypoglycemia, Type1diabetesView official trial listing → -
Completed NCT NCT06170905
Whey Protein Pre-load and Postprandial Glycemia in Pregnancy
Not yet reported University of Ulm 21 participants Est. completion 2025-10-22 1 siteOther conditions: Pregnancy, Postprandial GlycemiaView official trial listing → -
Completed NCT NCT06194955
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function
Not yet reported University of Copenhagen 50 participants Est. completion 2026-04-01 1 siteOther conditions: Incretin EffectView official trial listing → -
Status unknown NCT NCT06243536
The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients
Not yet reported University Hospital Sestre Milosrdnice 60 participants Est. completion 2024-12-31 1 siteType 2 diabetes Other conditions: Overweight, Disordered Eating BehaviorsView official trial listing → -
Active, not recruiting NCT NCT06260722
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
Not yet reported Eli Lilly and Company 1250 participants Est. completion 2027-01 77 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT06333132
Deciphering the Role of Incretin Hormones in Weight Loss-induced Remission of Type 2 Diabetes (DIABeat)
Not yet reported Azienda Ospedaliero, Universitaria Pisana 45 participants Est. completion 2026-02-01 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT06373146
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity
Not yet reported Eli Lilly and Company 392 participants Est. completion 2026-04-02 17 sitesOther conditions: ObesityView official trial listing → -
Completed NCT NCT06445075
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
Not yet reported Scholar Rock, Inc. 102 participants Est. completion 2025-06-17 7 sitesOther conditions: Overweight and ObesityView official trial listing → -
Status unknown NCT NCT06449235
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
Not yet reported Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders 938 participants Est. completion 2025-06 1 siteOther conditions: Type2diabetesView official trial listing → -
Completed NCT NCT06533527
Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
Not yet reported The Cleveland Clinic 69 participants Est. completion 2025-05-20 2 sitesType 2 diabetes Other conditions: Obesity, GastroparesisView official trial listing → -
Completed NCT NCT06584916
A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
Not yet reported Eli Lilly and Company 376 participants Est. completion 2025-11-21 29 sitesOther conditions: Obesity, OverweightView official trial listing → -
Not yet recruiting NCT NCT06671340
Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes
Not yet reported Elaine Chow 30 participants Est. completion 2026-01-31 1 siteType 2 diabetesPrediabetes Other conditions: Diabetes MellitusView official trial listing → -
Not yet recruiting NCT NCT06795360
Weight Changes After Incretin-mimetics
Not yet reported Medical College of Wisconsin 52 participants Est. completion 2031-11-30Other conditions: Obesity and Obesity-related Medical ConditionsView official trial listing → -
Completed NCT NCT06798220
Ultra-Processed Foods and Appetite Regulation: Acute Effects Across Body Mass Index Categories
Not yet reported Ondokuz Mayıs University 28 participants Est. completion 2025-01-15 1 siteOther conditions: Healthy Adult VolunteersView official trial listing → -
Active, not recruiting NCT NCT06801015
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
Not yet reported Mayo Clinic 30 participants Est. completion 2028-03-31 1 siteOther conditions: ObesityView official trial listing → -
Active, not recruiting NCT NCT06803888
Bariatric Surgery vs. Semaglutide vs. Tirzepatide
Not yet reported Ali Aminian 140 participants Est. completion 2027-12-01 1 siteOther conditions: Obesity and Obesity-related Medical ConditionsView official trial listing → -
Completed NCT NCT06881472
The Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Subjects With and Without Type 1 Diabetes
Not yet reported Asger Lund, MD 10 participants Est. completion 2026-01-16 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Active, not recruiting NCT NCT06923839
Testing the Potential Metabolic Effect of the Human Gut Bacterial Peptide, RUCILP, in Healthy Men
Not yet reported Oluf Pedersen 15 participants Est. completion 2026-04 1 siteOther conditions: Healthy Male AdultsView official trial listing → -
Enrolling by invitation NCT NCT06930495
The Effect of Adiposity on Muscle and Microvascular Function in HFpEF
University of Texas Southwestern Medical Center 95 participants Est. completion 2028-06-01 1 siteHeart failureView official trial listing → -
Completed NCT NCT06945419
A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
Not yet reported Eli Lilly and Company 219 participants Est. completion 2026-08-05 5 sitesType 2 diabetes Other conditions: Healthy, Overweight, ObesityView official trial listing → -
Not yet recruiting NCT NCT06950684
Impact of Protein Supplementation and Resistance Training on Body Composition, Functional Parameters, Metabolic Adaptation, and Nitrogen Balance in Adults Aged 45 Years and Older With Overweight or Obesity Receiving Incretin-based Medications
Not yet reported Assuta Medical Center 180 participants Est. completion 2028-07-01Other conditions: Obesity, Overweight (BMI > 25), Weight LossView official trial listing → -
Enrolling by invitation NCT NCT06959784
Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)
Not yet reported China-Japan Friendship Hospital 142 participants Est. completion 2026-12-31 1 siteCardiovascular disease Other conditions: Diabetes Mellitus, Cerebrovascular DiseaseView official trial listing → -
Active, not recruiting NCT NCT07115069
Comparison of Body Composition Changes With Weight Loss Interventions
Vanderbilt University Medical Center 60 participants Est. completion 2027-12 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT07240246
Effect of a Dietary Supplement on Hormones Involved in Appetite Regulation in Overweight and Obese Adults
Not yet reported FFoQSI - Austrian Competence Centre for Feed and Food Quality, Safety & Innovation 40 participants Est. completion 2026-05-12 1 siteOther conditions: GLP-1, Obesity &Amp; Overweight, Dietary SupplementView official trial listing → -
Not yet recruiting NCT NCT07288372
The CGM-OGTT Glycemic Homeostasis Study
Shanghai 6th People's Hospital 225 participants Est. completion 2027-08-10Type 2 diabetes Other conditions: Glucose Metabolism DisordersView official trial listing → -
Completed NCT NCT07417618
INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)
Brigham and Women's Hospital 60000 participants Est. completion 2026-06-19 1 siteType 2 diabetesCardiovascular disease Other conditions: OverweightView official trial listing → -
Not yet recruiting NCT NCT07546357
AIManage Using an AI-driven CDS and Chatbot
Not yet reported NYU Langone Health 16 participants Est. completion 2029-03-30 1 siteOther conditions: Diabetes, Obesity, Medication Side EffectsView official trial listing → -
Enrolling by invitation NCT NCT07640139
Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes
Indiana University 125000 participants Est. completion 2029-12-31 1 siteOther conditions: ObesityView official trial listing → -
Not yet recruiting NCT NCT07663591
Machine Learning Prediction of Respiratory Muscle Changes and Ventilatory Responses After Incretin-Based Therapy in Obesity
Biruni University 48 participants Est. completion 2026-07-30Other conditions: Obesity (BMI>30)View official trial listing → -
Enrolling by invitation NCT NCT07687589
The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy Individuals
Not yet reported University of Copenhagen 14 participants Est. completion 2027-04-28 1 siteOther conditions: EmesisView official trial listing → -
Completed NCT NCT07701005
Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity
Goztepe Prof Dr Suleyman Yalcın City Hospital 154 participants Est. completion 2026-04-15 1 siteOther conditions: Steatosis of Liver, Metabolic Liver Injury, Obesity, Overweight, Insulin ResistanceView official trial listing → -
Not yet recruiting NCT NCT07701291
Online Group Programme on Mindful Eating During Medication-Supported Weight Loss
Not yet reported Bern University of Applied Sciences 28 participants Est. completion 2027-08-15Other conditions: Obesity & Overweight, Emotional Eating, Emotional Eating Behaviour, Online InterventionView official trial listing → -
Not yet recruiting NCT NCT07711548
Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?
Not yet reported Knut Mai 292 participants Est. completion 2030-04Other conditions: Obesity & Overweight, Weight Loss MaintenanceView official trial listing → -
Not yet recruiting NCT NCT07761923
Preserving Muscle Mass During Incretin-Induced Weight Loss
Not yet reported Karolinska Institutet 20 participants Est. completion 2029-01-01 1 siteOther conditions: Obesity (BMI > 35)View official trial listing → -
Not yet recruiting NCT NCT07771166
Effects of N-Acyl Taurines on Incretin Levels in Healthy Subjects
Not yet reported University Hospital, Gentofte, Copenhagen 18 participants Est. completion 2028-12Other conditions: Cardiometabolic ConditionsView official trial listing → -
Completed NCT NCT07774208
FABP4 Response After Roux-en-Y Gastric Bypass
Istanbul University 28 participants Est. completion 2015-02-10Other conditions: Obesity (BMI>30), Obesity (BMI > 35), Insulin Resistance, Bariatric Surgery, Bariatric Surgery (Gastric Bypass)View official trial listing → -
Not yet recruiting NCT NCT07777575
Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide
Not yet reported Technical University of Munich 150 participants Est. completion 2027-05-31 1 siteOther conditions: Obesity (BMI>30)View official trial listing → -
Not yet recruiting NCT NCT07811011
Efficacy of Dapagliflozin Versus Metformin in Patients With Polycystic Ovary Syndrome
Not yet reported, Not yet reported Tanta University 70 participants Est. completion 2027-03-30Other conditions: Poly Cystic Ovary SyndromeView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
The Weekly Dose & livestreams
- Retatrutide Just Hit The Number That Changes Everything The Weekly Dose
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.